Literature DB >> 21090636

Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasma.

Christopher M Shuford1, Adam M Hawkridge, John C Burnett, David C Muddiman.   

Abstract

Biomarker discovery efforts in serum and plasma are greatly hindered by the presence of high abundance proteins that prevent the detection and quantification of less abundant, yet biologically significant, proteins. The most common method for addressing this problem is to specifically remove the few abundant proteins through immunoaffinity depletion/subtraction. Herein, we improved upon this method by utilizing multiple depletion columns in series, so as to increase the efficiency of the abundant protein removal and augment the detection/identification of less abundant plasma proteins. Spectral counting was utilized to make quantitative comparisons between undepleted plasma, plasma depleted with a single depletion column, and plasma depleted using two or three depletion columns in tandem. In the undepleted plasma only 29 lower abundance protein groups were identified with the top-scoring protein from each group having a median spectral count of 3, while in the plasma processed using a single HSA depletion column 61 such protein groups were identified with a median spectral count of 8. In comparison, 76 lesser abundant protein groups were identified with a median spectral count of 11.5 in the two column setup (i.e., HSA followed by MARS Hu14). However, in the ultimate depleted plasma sample, which was created using three depletion columns in tandem, the number of less abundant protein groups identified increase to 81 and the median spectral count for the top-scoring proteins from each group increased to 15 counts per protein. Moreover, exogenous B-type natriuretic peptide-32, which was added to the plasma as a detection benchmark at 12 μg/mL, was only detected in the plasma sample depleted using three depletion columns in tandem. Collectively, these data demonstrate that this method, tandem removal of abundant proteins or TRAP, provides superior removal efficiency compared to traditional applications and improves the depth of proteome coverage in plasma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21090636      PMCID: PMC3654688          DOI: 10.1021/ac102248d

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  54 in total

1.  Improved two-dimensional gel electrophoresis representation of serum proteins by using ProtoClear.

Authors:  B A Lollo; S Harvey; J Liao; A C Stevens; R Wagenknecht; R Sayen; J Whaley; F G Sajjadi
Journal:  Electrophoresis       Date:  1999 Apr-May       Impact factor: 3.535

2.  Comparison of label-free methods for quantifying human proteins by shotgun proteomics.

Authors:  William M Old; Karen Meyer-Arendt; Lauren Aveline-Wolf; Kevin G Pierce; Alex Mendoza; Joel R Sevinsky; Katheryn A Resing; Natalie G Ahn
Journal:  Mol Cell Proteomics       Date:  2005-06-23       Impact factor: 5.911

3.  Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure.

Authors:  Adam M Hawkridge; Denise M Heublein; H Robert Bergen; Alessandro Cataliotti; John C Burnett; David C Muddiman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

4.  Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide.

Authors:  J D Tissot; J A Schifferli; D F Hochstrasser; C Pasquali; F Spertini; F Clément; S Frutiger; N Paquet; G J Hughes; P Schneider
Journal:  J Immunol Methods       Date:  1994-07-12       Impact factor: 2.303

5.  Head-to-head comparison of serum fractionation techniques.

Authors:  Jeffrey R Whiteaker; Heidi Zhang; Jimmy K Eng; Ruihua Fang; Brian D Piening; Li-Chia Feng; Travis D Lorentzen; Regine M Schoenherr; John F Keane; Ted Holzman; Matthew Fitzgibbon; ChenWei Lin; Hui Zhang; Kelly Cooke; Tao Liu; David G Camp; Leigh Anderson; Julian Watts; Richard D Smith; Martin W McIntosh; Amanda G Paulovich
Journal:  J Proteome Res       Date:  2007-02       Impact factor: 4.466

6.  Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.

Authors:  B Mackness; M I Mackness; S Arrol; W Turkie; K Julier; B Abuasha; J E Miller; A J Boulton; P N Durrington
Journal:  Atherosclerosis       Date:  1998-08       Impact factor: 5.162

7.  Quantitation of vitronectin and clusterin. Pitfalls and solutions in enzyme immunoassays for adhesive proteins.

Authors:  K Høgåsen; T E Mollnes; J Tschopp; M Harboe
Journal:  J Immunol Methods       Date:  1993-03-15       Impact factor: 2.303

8.  Isolation of a protein Z-dependent plasma protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Determination of serum tetranectin: technical and clinical evaluation of three sandwich immunoassays.

Authors:  A V Thougaard; C K Høgdall; S K Kjaer; J Blaakaer; I Jaliashvili; M Christiansen
Journal:  Clin Chim Acta       Date:  1998-08-10       Impact factor: 3.786

Review 10.  CA 125: the past and the future.

Authors:  R C Bast; F J Xu; Y H Yu; S Barnhill; Z Zhang; G B Mills
Journal:  Int J Biol Markers       Date:  1998 Oct-Dec       Impact factor: 3.248

View more
  5 in total

1.  Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.

Authors:  Darue A Prieto; Donald J Johann; Bih-Rong Wei; Xiaoying Ye; King C Chan; Dwight V Nissley; R Mark Simpson; Deborah E Citrin; Crystal L Mackall; W Marston Linehan; Josip Blonder
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

2.  Evaluating the effects of preanalytical variables on the stability of the human plasma proteome.

Authors:  Maria E Hassis; Richard K Niles; Miles N Braten; Matthew E Albertolle; H Ewa Witkowska; Carl A Hubel; Susan J Fisher; Katherine E Williams
Journal:  Anal Biochem       Date:  2015-03-10       Impact factor: 3.365

3.  Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid.

Authors:  Seok-Won Hyung; Paul D Piehowski; Ronald J Moore; Daniel J Orton; Athena A Schepmoes; Therese R Clauss; Rosalie K Chu; Thomas L Fillmore; Heather Brewer; Tao Liu; Rui Zhao; Richard D Smith
Journal:  Anal Bioanal Chem       Date:  2014-09-06       Impact factor: 4.142

4.  Optimization of plasma sample pretreatment for quantitative analysis using iTRAQ labeling and LC-MALDI-TOF/TOF.

Authors:  Magdalena Luczak; Lukasz Marczak; Maciej Stobiecki
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

5.  Additions to the Human Plasma Proteome via a Tandem MARS Depletion iTRAQ-Based Workflow.

Authors:  Zhiyun Cao; Sachin Yende; John A Kellum; Renã A S Robinson
Journal:  Int J Proteomics       Date:  2013-02-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.